|
Volumn 182, Issue , 2010, Pages 321-341
|
Hormonal therapy of prostate cancer.
a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANDROGEN;
ANILIDE;
ANTIANDROGEN;
BICALUTAMIDE;
HORMONE;
NITRILE;
PROSTATE SPECIFIC ANTIGEN;
TOLUENESULFONIC ACID DERIVATIVE;
ARTICLE;
BIOLOGICAL MODEL;
BLOOD;
CASTRATION;
CLINICAL TRIAL;
HUMAN;
MALE;
METABOLISM;
METHODOLOGY;
NEOPLASM;
PATHOLOGY;
PROSTATE;
PROSTATE TUMOR;
ANDROGEN ANTAGONISTS;
ANDROGENS;
ANILIDES;
CASTRATION;
CLINICAL TRIALS AS TOPIC;
HORMONES;
HUMANS;
MALE;
MODELS, BIOLOGICAL;
NEOPLASMS, HORMONE-DEPENDENT;
NITRILES;
PROSTATE;
PROSTATE-SPECIFIC ANTIGEN;
PROSTATIC NEOPLASMS;
TOSYL COMPOUNDS;
MLCS;
MLOWN;
|
EID: 77956625246
PISSN: None
EISSN: 18757855
Source Type: Journal
DOI: 10.1016/s0079-6123(10)82014-x Document Type: Article |
Times cited : (30)
|
References (0)
|